Budget STT Hike Sparks Market Sell-off; Analysts Select 9 Stocks

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorKavya Nair|Published at:
Budget STT Hike Sparks Market Sell-off; Analysts Select 9 Stocks
Overview

Indian equity benchmarks Sensex and Nifty experienced a significant decline of approximately 2% following the Union Budget 2026 announcement on February 1, 2026. While the budget emphasized fiscal prudence and a substantial increase in capital expenditure, a hike in Securities Transaction Tax (STT) on futures and options, coupled with a lack of specific measures for capital flow management, led to investor apprehension. Despite the broad market correction, analysts have pinpointed nine stocks across healthcare, automotive, pharmaceuticals, infrastructure, hospitality, IT, and electronics manufacturing sectors that they believe are well-positioned to benefit from budget allocations and prevailing economic trends.

### Market Reaction to Budget 2026

Indian equity benchmarks Sensex and Nifty experienced a sharp sell-off, shedding approximately 2% on Sunday, February 1, 2026. The downturn followed the Union Budget's announcement, which, while largely meeting expectations on fiscal prudence with a targeted deficit of 4.3% for FY27 and a 9% increase in capital expenditure to ₹12.2 lakh crore, introduced elements that unsettled investors. The market's immediate reaction highlighted a sensitivity to increased transaction costs and a perceived lack of immediate stimulus beyond ongoing infrastructure spending [2, 4, 34].

### Disappointment Over STT Hike and F&O Impact

The primary catalyst for the market's jitters appeared to be an increase in the Securities Transaction Tax (STT) levied on futures and options trading. Experts suggest this move could negatively impact domestic brokerages and significantly deter foreign institutional investors (FIIs), who frequently utilize the F&O segment for hedging strategies [16, 38]. The STT on futures has been raised from 0.02% to 0.05%, and on options from 0.10% to 0.15% [16, 24]. This hike is seen as a measure to curb speculation and generate revenue, but it directly increases trading costs, making India relatively less competitive for short-term and derivative-oriented foreign flows. Concerns also surfaced regarding the absence of direct measures for capital flow management or currency stability, further weighing on investor sentiment [2, 5, 16, 38].

Ashish Gupta, CIO at Axis Mutual Fund, described the budget as a "mixed bag," highlighting the stable tax regime but acknowledging disappointment stemming from STT increases and the borrowing program. Harish Krishnan, CIO – Equity at Aditya Birla Sun Life AMC, noted the budget's realism and fiscal prudence, observing a strategic shift from supply-side capex stimulus towards domestic consumption support. He cautioned that elevated borrowing levels might cause near-term discomfort but maintained that expectations remain conservative for the medium term [1].

### Sectoral Focus and Analyst Stock Selections

Amidst the market volatility, several analysts have identified specific stocks poised to benefit from budget allocations and broader economic trends. The budget's emphasis on infrastructure, AI, digital services, and specific manufacturing sectors provided a backdrop for these selections.

Siddhartha Khemka from Motilal Oswal Financial Services highlighted Apollo Hospitals Enterprises (Current Price: ₹6,948; P/E: 59.8 [12, 25]) for its potential to benefit from regional medical tourism initiatives and the Biopharma Shakti mission. Mahindra & Mahindra (Current Price: ₹3,364; P/E: 29.4 [6]) was flagged for its potential gains from the ₹1 lakh crore infrastructure capex and a continued focus on farm mechanization. Biocon (Target: ₹460) is expected to capitalize on the Biopharma Shakti mission, aligning with its diabetes and oncology portfolios, while Larsen & Toubro (Current Price: ₹3,814; P/E: 31.5 [10, 31]) is set to benefit from infrastructure equipment support and the revival of industrial clusters, with a capex boost for railways and roads [4, 10, 13, 31].

Shrikant Chouhan of Kotak Securities pointed to Indian Hotels Company (Current Price: ₹664; P/E: 56.0 [11, 22]) as a key player in India's hospitality sector, poised to benefit from favourable demand-supply dynamics. He also noted Tata Consultancy Services (Current Price: ₹3,187; P/E: 22.6 [8, 23, 27, 46]), emphasizing its strategic focus on AI and large deals, supported by a tax holiday for foreign cloud service providers [44].

Devarsh Vakil from HDFC Securities recommended Sai Life Sciences in light of the Biopharma SHAKTI proposals and the growing Indian CRDMO market. Syrma SGS Technology (Target: ₹920) is set to gain from increased outlay for the Electronics Components Manufacturing Scheme, with proposed outlay to ₹40,000 crore for FY26-27. Zensar Technologies (Current Price: ₹667; P/E: 20.0 [9, 45]) was noted for its strategic shift towards AI-driven solutions and cross-sector diversification aligned with the 'intelligence-first' approach of the budget [9, 45].

### Forward Outlook and Sectoral Trends

The Union Budget 2026-27 reinforces a commitment to infrastructure-led growth, with public capital expenditure increased to a record ₹12.2 lakh crore for FY27, an 11.5% rise over the previous year's estimates [13, 34]. This significant allocation is expected to drive demand in sectors like construction, capital goods, cement, and logistics. The focus on AI, data centers, and digital infrastructure, including tax holidays for foreign cloud service providers until 2047, signals a strategic pivot towards technology as a growth engine [4, 44, 47]. While the STT hike introduces short-term headwinds for trading volumes and FII participation in derivatives, the long-term outlook for sectors aligned with the budget's capex and technology agenda remains cautiously optimistic among analysts.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.